The Future of GLP-1 Medications in Cardiology As research continues, the role of GLP-1 medications in cardiovascular health is expanding beyond diabetes management
"Cada kilogramo perdido puede significar una mejora en la salud cardiovascular y una reduccin en el riesgo de diabetes y cncer", concluye la experta
In these cardiovascular safety trials, in secondary or exploratory analyses, GLP-1 receptor agonists were also shown to reduce macro-albuminuria, an accepted surrogate marker for diabetic kidney disease (DKD), a condition that still represents a major unmet medical need
Time Medications Wisely Space out thyroid meds, PPIs, and antacids
Inflammatory cytokines in atherosclerosis: Current therapeutic approaches
While GLP-1s have proven life-changing for people with diabetes, obesity, and other medical conditions, using them for cosmetic weight loss has always seemed a little extreme to me, at least for noncelebrities whose very income doesnt hinge on fitting societys expectations of what a person should look like